ABBV: AbbVie Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 312,058.74
Enterprise Value ($M) 358,919.74
Book Value ($M) 12,129.00
Book Value / Share 6.87
Price / Book 25.73
NCAV ($M) -91,312.00
NCAV / Share -51.72
Price / NCAV -3.42

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.30

Liquidity (mrq)
Quick Ratio 0.76
Current Ratio 0.87

Balance Sheet (mrq) ($M)
Current Assets 33,002.00
Assets 134,711.00
Liabilities 124,314.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 54,318.00
Operating Income 17,425.00
Net Income 4,863.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 22,839.00
Cash from Investing -2,009.00
Cash from Financing -17,222.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.08 1.30
01-25 13G/A BlackRock Inc. 8.10 3.23

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-02-23 456,959 3,941,923 11.59
2024-02-22 659,676 4,852,394 13.59
2024-02-21 604,862 3,819,124 15.84
2024-02-20 733,991 5,484,327 13.38

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA


Financial data and stock pages provided by
Fintel.io